A synthetic triple agonist peptide studied in laboratory research on GIP, GLP-1, and glucagon receptor signaling in experimental models. Supplied lyophilized for laboratory research use only — not for human consumption, veterinary use, clinical application, or therapeutic treatment.
Retatrutide
Price range: $52.00 through $108.00
Retatrutide (LY3437943) is a synthetic single-chain peptide studied in laboratory research as a triple agonist at the GIP, GLP-1, and glucagon receptors. It is used in structured in vitro and model-based studies designed to yield reproducible observations under standardized conditions.
- Synthetic fatty acid-modified peptide supplied for laboratory research use only.
- Referenced in published research examining simultaneous agonism across three incretin and glucagon receptor subtypes in experimental models.
- Studied in research on incretin receptor signaling and energy substrate metabolism pathways.
- Suitable for controlled, repeatable studies investigating multi-receptor endocrine pathway mechanisms.
Research Disclaimer: Second Wind Research products are sold exclusively for laboratory and scientific research. They are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.
| Size | 10 mg, 20 mg, 30 mg |
|---|
Related products
Updating…